Yep obviously I'm completely speculating about the timing. I might be wrong and they won't sell it but Jason Loveridge has a track record in M&A, he is ex Nomura. In one of the IXC virtual presentations last year he emphasised that he had been involved with negotiating the sale of several companies in years gone by in the Biotech sector.
Ann: Postcard to Shareholders, page-29
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
